hotspot -WSS

hotspot

author：hotspot 2025-09-03 08:27:43 - browse：72

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： BIO selects John Crowley as new CEO

hotspot

WSS

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

CDC backtracks, saying fully vaccinated people can go maskless indoors

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Court strikes down limits on filming of police in Arizona

focus

hotspot

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Fetal surgery at risk from Dobbs and new abortion restrictions

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Cancer drug shortages should be causing more outrage

Rep. Raul Ruiz on the physician shortage and more

Affirmative action in medical school literally saved lives

Court strikes down limits on filming of police in Arizona

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pediatric cancer treatments threatened by a new FDA policy

hotspot

Cigna, Humana reportedly in talks to merge

AbbVie dramatically boosts its spending on lobbying

Rep. Raul Ruiz on the physician shortage and more

Disappointing trial forces Pfizer to pivot on obesity medicine plans

How artificial intelligence is being used to detect, treat cancer

J&J to emphasize cancer drugs, stop much of its vaccine research

focus

Wikipedia

hotspot

Wikipedia